Jean-Paul St-Pierre

Plus aucun poste en cours

Health Technology

Consumer Services

Process Industries

Provenance du réseau au premier degré de Jean-Paul St-Pierre

Entité	Type d'entité	Industrie
Ambrilia Biopharma, Inc. Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. 8	Private Company	Pharmaceuticals: Major	8

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Jean-Paul St-Pierre via son réseau personnel

Société	Secteur	Personnes liées	Poste principal
Immunex Corp. Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation	Biotechnology	Jinzi Wu	Corporate Officer/Principal
BELLUS HEALTH	Pharmaceuticals: Major	Philippe Calais	Corporate Officer/Principal
THERATECHNOLOGIES INC.	Pharmaceuticals: Major	Luc Tanguay	Chief Executive Officer
SANOFI	Pharmaceuticals: Major	Paul-Henry Schmelck	Corporate Officer/Principal
COHBAR, INC.	Biotechnology	Philippe Calais	Chief Executive Officer
NOVARTIS AG	Pharmaceuticals: Major	Jinzi Wu	Corporate Officer/Principal
GSK PLC	Pharmaceuticals: Major	Jinzi Wu	Corporate Officer/Principal
SANOFI INDIA LIMITED	Pharmaceuticals: Major	Jinzi Wu	Corporate Officer/Principal
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Biotechnology	Philippe Calais	Corporate Officer/Principal
Apicap SAS Apicap SAS Investment ManagersFinance Apicap SAS is a Venture Capital firm, a subsidiary of OTC Holding SAS founded in 2001. Apicap SAS is headquartered in Paris.	Investment Managers	Paul-Henry Schmelck	Private Equity Investor
University of Arizona	College/University	Jinzi Wu	Doctorate Degree
PrimeBioTech PrimeBioTech Medical DistributorsDistribution Services PrimeBioTech develops therapeutic products based on gene therapy technologies. The private company is based in Paris, France.	Medical Distributors	Paul-Henry Schmelck	President
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Pharmaceuticals: Major	Jinzi Wu	Corporate Officer/Principal
NEOVACS	Pharmaceuticals: Major	Paul-Henry Schmelck	Director/Board Member
University of Sherbrooke	College/University	Luc Tanguay	Graduate Degree
Université Paris 1 Panthéon-Sorbonne	College/University	Paul-Henry Schmelck	Doctorate Degree
Nanjing University	College/University	Jinzi Wu	Graduate Degree
Université François-Rabelais de Tours	College/University	Philippe Calais	Doctorate Degree
W SAS W SAS Internet Software/ServicesTechnology Services W SAS owns and operates an online portal for e-greetings. It offers a collection of e-greetings for festivals, wishes, entertainment, sentiments, cultures, and other situations. The company was founded by Dany Rafik Smati and is headquartered in Puteaux, France.	Internet Software/Services	François Lombard	Director/Board Member
Neurochem (International) Ltd. Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland.	Miscellaneous Commercial Services	Philippe Calais	President
Servier Canada, Inc. Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Servier Canada, Inc. provides healthcare services. It manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause. The company was founded in 1978 and is headquartered in Quebec, Canada.	Pharmaceuticals: Major	Philippe Calais	Corporate Officer/Principal
NANOBIOTIX	Medical Specialties	Paul-Henry Schmelck	Corporate Officer/Principal
Univalor, Inc. Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada.	Miscellaneous Commercial Services	Philippe Calais	Chief Executive Officer
BIOBank SA BIOBank SA Medical/Nursing ServicesHealth Services BIObank SA engages in human tissue development. It prepares, preserves, distributes, and transfers tissues for therapeutic human use. The company was founded by Philippe Chaix, Pierre Lory, and William Gazi on November 4, 1999 and is headquartered in Lieusaint, France.	Medical/Nursing Services	François Lombard	Director/Board Member
ACROPOLIS TELECOM	Specialty Telecommunications	François Lombard	Director/Board Member
SAGIMET BIOSCIENCES INC.	Pharmaceuticals: Major	Jinzi Wu	Director/Board Member
Solem SAS Solem SAS Industrial MachineryProducer Manufacturing Solem SAS manufactures hardware materials. It specializes in hoisting and handling equipment. The company was founded on July 21, 1987 and is headquartered in Epinay-sur-Seine, France.	Industrial Machinery	François Lombard	Director/Board Member
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China.	Medical Specialties	Jinzi Wu	Chief Executive Officer
The BayHelix Group		Jinzi Wu	Corporate Officer/Principal
Pets Health Pty Ltd.		François Lombard	Director/Board Member
PhageTech, Inc. PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA.	Miscellaneous Commercial Services	Jinzi Wu	Corporate Officer/Principal
MatriSys Bioscience, Inc. MatriSys Bioscience, Inc. BiotechnologyHealth Technology MatriSys Bioscience, Inc. engages in the development of biologic therapeutics. It offers therapies for dermatology and skin care conditions including atopic dermatitis, rosacea, psoriasis, acne, and skin infections. The company was founded by Mark S. Wilson and Richard L. Gallo in 2015 and is headquartered in La Jolla, CA.	Biotechnology	Philippe Calais	Chief Executive Officer
ASCLETIS PHARMA INC.	Biotechnology	Jinzi Wu	Chief Executive Officer
Rfas 4 Rfas 4 Financial ConglomeratesFinance Rfas 4 functions as an investment holding French company. The private company is based in Paris, France. and has subsidiaries in France.	Financial Conglomerates	François Lombard	Chairman
TRANSCODE THERAPEUTICS, INC.	Biotechnology	Philippe Calais	Chairman
Ascletis BioScience Co., Ltd.		Jinzi Wu	Chief Executive Officer
Phileas Pharma, Inc.		Philippe Calais	Founder
Isarna Therapeutics BV Isarna Therapeutics BV Financial ConglomeratesFinance Isarna Therapeutics BV is an investment holding Dutch company. The private company is based in Zevenbergen, Netherlands.	Financial Conglomerates	Philippe Calais	Chief Executive Officer
Cite Des Biotechs De Laval		Philippe Calais	Director/Board Member
Cognisense		Philippe Calais	Director/Board Member
Gannex Pharma Co Ltd.		Jinzi Wu	Chief Executive Officer
Ascletis Pharma China Co., Ltd.		Jinzi Wu	Director/Board Member
Ascletis Xinnuo Medicine Co., Ltd		Jinzi Wu	Chief Executive Officer
Soundridge Pharmaceuticals (Hong Kong) Co., Ltd.		Jinzi Wu	Director/Board Member
Gannex LLC		Jinzi Wu	Corporate Officer/Principal
Ascletis Pharmaceuticals Co., Ltd.		Jinzi Wu	Corporate Officer/Principal
ADHERA THERAPEUTICS, INC.	Pharmaceuticals: Major	Philippe Calais	Director/Board Member
Autotelic, Inc. Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Autotelic, Inc. manufactures therapeutics drugs. Its Therapeutic Drug Monitoring (TDM) device which allows PK guided dosing, reducing the toxicity from overmedication and increasing the efficacy from under-medication. The company was founded in 2013 and is headquartered in Costa Mesa, CA.	Pharmaceuticals: Major	Philippe Calais	Director/Board Member